{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:58:24Z","timestamp":1790888304350,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.compbiolchem.2024.108132","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T05:23:52Z","timestamp":1719206632000},"page":"108132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2"],"prefix":"10.1016","volume":"112","author":[{"given":"Deepesh Kumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Sobhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2024.108132_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100721","article-title":"Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses","volume":"53","author":"Artese","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04743","article-title":"Molecular biology of coronaviruses: current knowledge","volume":"6","author":"Artika","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib5","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","article-title":"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity","volume":"79","author":"Barretto","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019-new coronavirus epidemic: evidence for virus evolution","volume":"92","author":"Benvenuto","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","article-title":"Covalent inhibitors design and discovery","volume":"138","author":"De Cesco","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11224-022-02036-5","article-title":"In silico studies of Mpro and PLpro from SARS-CoV-2 and a new class of cephalosporin drugs containing 1, 2, 4-thiadiazole","volume":"33","author":"Delgado","year":"2022","journal-title":"Struct. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib10","doi-asserted-by":"crossref","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib11","article-title":"Human coronavirus reinfection dynamics: lessons for SARS-CoV-2","volume":"2020","author":"Edridge","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib14","first-page":"1","article-title":"Identification of prospective covalent inhibitors for SARS-CoV-2 main protease using structure-based approach","author":"Gayatri","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib15","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1080\/07391102.2022.2129453","article-title":"Identification of prospective covalent inhibitors for SARS-CoV-2 main protease using structure-based approach","volume":"41","author":"Gayatri","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib16","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1021\/bi0504761","article-title":"Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition","volume":"44","author":"Han","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib17","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1128\/JVI.78.24.13600-13612.2004","article-title":"Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity","volume":"78","author":"Harcourt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174082","article-title":"Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases","volume":"901","author":"Jade","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/0026897021000044025","article-title":"Constant pressure-constant temperature molecular dynamics: a correct constrained NPT ensemble using the molecular virial","volume":"101","author":"Kalibaeva","year":"2003","journal-title":"Mol. Phys."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib22","article-title":"Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib23","first-page":"43","article-title":"Vaccines for COVID-19: the current state of play","volume":"35","author":"Koirala","year":"2020","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/nar\/gkg161","article-title":"Survey and summary: structural classification of zinc fingers","volume":"31","author":"Krishna","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib25","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib26","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1039\/C7CS00220C","article-title":"Structure-based design of targeted covalent inhibitors","volume":"47","author":"Lonsdale","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a FlipGFP-based reporter assay","volume":"7","author":"Ma","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib28","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bmcl.2013.10.003","article-title":"Drug discovery considerations in the development of covalent inhibitors","volume":"24","author":"Mah","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib30","first-page":"3","article-title":"Properties of coronavirus and SARS-CoV-2","volume":"42","author":"Malik","year":"2020","journal-title":"Malays. J. Pathol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib32","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/acs.jpcb.1c04556","article-title":"Accelerating COVID-19 research using molecular dynamics simulation","volume":"125","author":"Padhi","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41562-020-0911-0","article-title":"Pandemic publishing poses a new COVID-19 challenge","volume":"4","author":"Palayew","year":"2020","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib34","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107956","article-title":"Computational analysis of the interactions between Ebselen and derivatives with the active site of the main protease from SARS-CoV-2","volume":"107","author":"Rieder","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1586\/erv.09.43","article-title":"SARS vaccines: where are we?","volume":"8","author":"Roper","year":"2009","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti\u2013COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib38","article-title":"Research square","author":"Sanders","year":"2021","journal-title":"Potent Sel. covalent Inhib. papain- Protease SARS-CoV-2"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","article-title":"Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2","volume":"14","author":"Sanders","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural proteins in severe acute respiratory syndrome coronavirus-2","volume":"51","author":"Satarker","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib42","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","article-title":"Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity","volume":"65","author":"Shen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib43","article-title":"Potent, novel SARS-CoV-2 PLpro inhibitors block viral replication in monkey and human cell cultures","author":"Shen","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib45","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1021\/acs.jmedchem.1c02134","article-title":"The ascension of targeted covalent inhibitors","volume":"65","author":"Singh","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib46","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1039\/D0MD00154F","article-title":"Covalent inhibitors: a rational approach to drug discovery","volume":"11","author":"Sutanto","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib47","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","article-title":"Progress and challenges in targeting the SARS-CoV-2 papain-like protease","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib48","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.adm9724","article-title":"Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model","volume":"383","author":"Tan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib49","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz-Tomczak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2024.108132_bib51","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.compbiolchem.2024.108132_bib52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.21608\/jmals.2024.333814","article-title":"The COVID-19 JN. 1 variant diagnosed in Egypt","volume":"5","author":"Yameny","year":"2023","journal-title":"J. Med. Life Sci."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T06:44:14Z","timestamp":1728283454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":52,"alternative-id":["S1476927124001208"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108132","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108132"}}